P PRIMESTOCKFINDER.COM

ABT Stock Abbott Laboratories

US · NYSE
$104.88 +1.14% Prices as of close 2026-10-27

Last in our picks 2026-10-26 — not in the current list; analysis below is from that screen

Diversified diagnostics, devices, and nutrition businesses provide resilient growth and downside protection.

Future value: $120.72 (+16.41%) · 6-12 months · analyst consensus

  • ▸Defensive diversification and steady healthcare demand.
  • ▾Below 50-day MA (-1.4%)
  • ▸Above 200-day MA — long-term uptrend

Trend: ABT is trading below the 50-day average (-1.40%), RSI 50 — neutral momentum, with a 3-month return of -0.76%.

Valuation & quality: Abbott Laboratories trades on a trailing P/E of 39.0, forward P/E 17.6, PEG 1.94, price-to-book 3.55; fundamentals show net margin 9.7%, revenue growth 14.5% year on year.

Analyst consensus: 26 analysts have a mean 12-month price target of $118.52 (+13% vs the last close; range $100.00 – $130.00), consensus rating “strong buy”.

Income: trailing dividend yield 2.43%.

Our screen: BUY (score 2) — Diversified diagnostics, devices, and nutrition businesses provide resilient growth and downside protection.

Computed from end-of-day data; not personal advice.

Our simulated $10,000 funds have traded ABT 1 time — 0 of 1 closed trade profitable.

FundBoughtSoldReturn
US Low-risk2026-09-24 @ $103.492026-09-29 @ $100.98 · AI review sell-2.43%

Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.

116.7 82.6 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-09 → 2026-10-23 (USD). Range 82.6 – 116.7.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-11.80%-11.60%-5.70%+6.00%+16.50%+4.40%-10.40%+4.90%
Market cap
$182.68B
P/E (ttm)
39.0
Forward P/E
17.6
EPS (ttm)
$2.69
Price / book
3.55
PEG
1.94
Beta
0.58
Net margin
9.7%
Revenue growth
14.5%
Earnings growth
-43.7%
Revenue (ttm)
$48.23B
Debt / equity
63%
Dividend yield
2.43%
52-wk range
$81.97 – $132.03
Volume
7,840,018
Avg volume (3m)
9,037,279
Mean target
$118.52
Low
$100.00
High
$130.00
Analysts
26
Consensus
STRONG BUY
RSI (14)
49.7
vs 50-day MA
-1.40%
1-mo return
+2.60%
3-mo return
-0.76%
Volume z-score
1.84

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

Sector: Healthcare · Industry: Medical Devices · United States · 122,000 employees · Website

Browse: all US stocks · Health Care picks · today's movers

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.